MitoSciences was founded in 2004 with the mission of supporting critical research areas in cancer, neurodegeneration and metabolic disorders.

We produce and distribute immunoassays and high performance monoclonal antibodies via an online catalog consisting of over 400 products in the areas of metabolism and apoptosis. We have placed considerable investment into developing novel and effective techniques for screening, characterizing, and validating monoclonal antibodies.

MitoSciences was acquired by Abcam in May of 2011. Our products can be reviewed on our website and are available for sale through Abcam.

MitoSciences/Abcam is the market leader in mitochondrial research products.